SOFOSBUVIR

Project Description

Hepatitis C virus nucleotide analog NS5B polymerase inhibitor indicated in the treatment of chronic hepatitis C infection

Systematic Name: N-[[P(S),2′R]-2′-Deoxy-2′-fluoro-2′-methyl-P-phenyl-5′-uridylyl]-l-alanine 1-methylethyl ester

Trade Name(s): Sofosbuvir, Sovaldi, Soforal

Molecular Formula: C22H29FN3O9P

Molecular Weight: 529.453 g/mol

Therapeutic Category: Antiviral; nucleotide analog HCV NS5B polymerase inhibitor.

 

Project Type
  • Chemical Product -

Footer

About Us

PBIC was established in 2015 as a dedicated facility for the production of Active Pharmaceutical Ingredients (APIs) and associated chemicals such as intermediates.  The site was commissioned in January 2015 and production started April, 2016.

Contact

  • Phone: +20 01066900043
  • Fax: +(203) 4626 026
  • Email: info@pbichem.com Planning@pbichem.com
  • Address: Borg El-Arab 2nd Industrial Zone, Alexandria, Egypt.

EXTRA NAVIGATION